IN8bio, Inc.
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologou…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
IN8bio, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
IN8bio, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of IN8bio, Inc..